Cardiovascular Diseases

The department investigates atherosclerotic cardiovascular disease and elevated Lipoprotein(a), aiming to test new agents that may lower the incidence of coronary heart disease death, myocardial infarction, and urgent revascularization.

  • Atherosclerotic cardiovascular disease
  • Coronary heart disease death
  • Myocardial infarction
  • Urgent coronary revascularization
  • Lipoprotein(a) reduction

Centrum klinickeho vyzkumu s.r.o. collaborates with local investigators to evaluate the effectiveness of novel therapies for heart health.

Nutritional and Metabolic Diseases

The research program addresses obesity and overweight, evaluating the potential of tirzepatide to reduce morbidity and mortality linked to excess weight and metabolic dysfunction.

  • Obesity management
  • Weight reduction strategies
  • Metabolic risk improvement
  • Morbidity and mortality outcomes
  • Dual GLP‑GIP agonist therapy

As a commercial organization, the site accelerates the translation of metabolic research into accessible patient solutions.